Thea Supplement: Use of Intracameral Cefuroxime

In 2007, results from the ESCRS Endophthalmitis Prophylaxis Study showed that intracameral cefuroxime significantly reduced the risk of endophthalmitis after cataract surgery [ESCRS Endophthalmitis Study Group. J Cataract Refract. Surg. 2007;33:978-988]. Then in 2012, a major obstacle to systematic intracameral use was eliminated when Aprokam® (cefuroxime 50mg powder for injection; Laboratoires Théa) was approved across Europe as the first and only product indicated for intracameral administration to prevent endophthalmitis after cataract surgery. As of September, 2014, this single-use agent is available in 23 European countries, with approval being sought elsewhere around the world. Download Supplement

Tags: endophthalmitis

Latest Articles

Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.